These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 11741371)
21. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: novel application of the cutting balloon. Polin N; Feldman D; Naidu SS J Invasive Cardiol; 2006 Sep; 18(9):436-7. PubMed ID: 16954586 [No Abstract] [Full Text] [Related]
22. Intracoronary aspiration for bailout management of the no-reflow during percutaneous coronary intervention. Min PK; Ko YG; Jang Y Int J Cardiol; 2006 May; 109(3):402-5. PubMed ID: 15967519 [TBL] [Abstract][Full Text] [Related]
23. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum]. Veselka J Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555 [TBL] [Abstract][Full Text] [Related]
24. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy]. Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820 [TBL] [Abstract][Full Text] [Related]
25. Coronary artery ectasia: still an unknown phenomenon. Cay S Int J Cardiol; 2010 Dec; 145(3):515. PubMed ID: 20036022 [No Abstract] [Full Text] [Related]
27. New approach to septal ablation: glue (cyanoacrylate) septal ablation. Oto A; Aytemir K; Deniz A Catheter Cardiovasc Interv; 2007 Jun; 69(7):1021-5. PubMed ID: 17525960 [TBL] [Abstract][Full Text] [Related]
28. [Assessment of catheter drive and measurement collection in a coronary vessel model for the PTCA catheter]. Kraft M; Wendt O; Rutsch W; Boenick U Biomed Tech (Berl); 1997; 42 Suppl():484-5. PubMed ID: 9517248 [No Abstract] [Full Text] [Related]
29. Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Hori Y; Ueda M; Nakayama T; Saegusa N; Uehara M; Lee K; Sekine T; Daimon M; Kobayashi Y; Funabashi N; Komuro I Int J Cardiol; 2007 Jul; 119(3):403-7. PubMed ID: 17069908 [TBL] [Abstract][Full Text] [Related]
30. [No-reflow phenomenon occurring during elective angioplasty performed due to in-stent restenosis -- a case report]. Dobrzycki S; Nowak K; Kozuch M; Bachórzewska-Gajewska H; Poniatowski B; Zuk J Kardiol Pol; 2006 Apr; 64(4):437-40. PubMed ID: 16699996 [TBL] [Abstract][Full Text] [Related]
31. MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Amano Y; Takayama M; Kumita S; Kumazaki T J Comput Assist Tomogr; 2007; 31(4):600-4. PubMed ID: 17882040 [TBL] [Abstract][Full Text] [Related]
33. Surgical removal of entrapped and broken percutaneous transluminal coronary angioplasty balloon catheter. Singh J; Thingnam SK; Das D; Singh H; Sharma R; Vijayvergia R Interact Cardiovasc Thorac Surg; 2007 Feb; 6(1):94-6. PubMed ID: 17669780 [TBL] [Abstract][Full Text] [Related]
34. Hypertrophic obstructive cardiomyopathy and septal ablation. Steinbis S Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780 [No Abstract] [Full Text] [Related]
35. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Rezkalla SH; Kloner RA Catheter Cardiovasc Interv; 2008 Dec; 72(7):950-7. PubMed ID: 19021281 [TBL] [Abstract][Full Text] [Related]
36. [Ablation and implantation of implantable cardioverter defibrillator in a case of hypertrophic cardiomyopathy with atrioventricular nodal reentrant tachycardia]. Vural A; Ağaçdiken A; Ural D; Kiliç T; Kozdağ G; Kahraman G; Ural E; Komşuoğlu B Anadolu Kardiyol Derg; 2004 Mar; 4(1):92-5. PubMed ID: 15033628 [No Abstract] [Full Text] [Related]
37. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467 [TBL] [Abstract][Full Text] [Related]
38. [The potential of magnetic resonance imaging for the surveillance of septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A case report]. Chassaing S; Garrigoux P; Redheuil A; Blanchard D; Bar O; Maudière A; Mousseaux E Arch Mal Coeur Vaiss; 2006 Sep; 99(9):828-31. PubMed ID: 17067103 [TBL] [Abstract][Full Text] [Related]
39. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction]. Yang YJ; Zhao JL Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176 [No Abstract] [Full Text] [Related]
40. Epinephrine: a new pharmacologic treatment for no-reflow? Baim DS Catheter Cardiovasc Interv; 2002 Nov; 57(3):310-1. PubMed ID: 12410504 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]